Navigation Links
Accera Announces Initiation of Clinical Trial for AC-1204
Date:11/26/2012

imately 60 clinical sites in the US and is expected to enroll more than 400 patients.  This study will evaluate the effects of once daily dosing of AC-1204 for 26 weeks on cognition, pharmacokinetic measures, activities of daily living, resource utilization, and quality of life among subjects with mild-to-moderate AD. 

The primary endpoint will examine the effects of AC-1204 on memory and cognition as measured by the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-Cog) after 26 weeks among both carriers and non carriers of the epsilon 4 variant of the gene apolipoprotein E (APOE4).  Previous studies demonstrated proof of concept for the company's unique approach. 

About Accera 
Accera, Inc. is a privately held commercial-stage healthcare company that developed and now markets Axona in the US.  Accera is engaged in the research, development and commercialization of other clinical applications for Axona and AC-1204 in acute and chronic neurodegenerative diseases.  For more information about Accera, please visit www.accerapharma.comAccera, Inc.

Tiberend Strategic Advisors, Inc.(303) 999-3705

(212) 827-0020Bill Poncy

Andrew MielachVP Commercial Development

amielach@tiberend.com bponcy@accerapharma.com
'/>"/>

SOURCE Accera, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Calif. , June 30, 2015  Avanir ... PRISM II study showing that treatment with NUEDEXTA ... reduction in symptoms of pseudobulbar affect (PBA) in ... PBA is a distressing condition characterized by sudden ... from certain neurologic diseases or brain injury. PRISM ...
(Date:6/30/2015)... -- July 4 th is this weekend, a time we ... people behind it. To help honor our current nation,s heroes, ... Medical Card, a leading provider of free pharmacy ... independence for our disabled military veterans, police, firemen, and EMS ... prescriptions. "Due to USA ...
(Date:6/30/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/pggcjf/global_endoscopy ) ... Endoscopy Devices Market 2015-2019" report to their ... to grow at a CAGR of 5.53% over ... market can be segmented into three based on ... market can be further segments in terms of ...
Breaking Medicine Technology:Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 3
... that it will report its 2011 first quarter earnings on Friday, ... host an analyst and investor call at 10:00 AM EDT live ... participate in the conference call within the U.S. and Canada, dial ... dial (708) 290-1340. The conference ID is 74735682. ...
... 14, 2011 Cardinal Health today opened its first ... its nationwide capability to manufacture molecular imaging biomarkers that ... cancer, neurological disorders and heart disease. Cyclotrons ... Tomography (PET) molecular imaging agents, one of the fastest-growing ...
Cached Medicine Technology:Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 2Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 3
(Date:6/30/2015)... Utah (PRWEB) , ... June 30, 2015 , ... Rocky ... it has restructured its management team and added a new CEO, Mr. Darold Francis. ... industry leading selection of premium essential oils that customers have come to know and ...
(Date:6/30/2015)... ... June 30, 2015 , ... MJH Associates ... HRA Healthcare Research & Analytics , a consultative healthcare market research practice ... family of businesses. HRA offers quantitative and qualitative, custom and multi-client primary market ...
(Date:6/30/2015)... ... June 30, 2015 , ... An opinion piece published ... transfer procedures had over breast implants when reconstructing breasts after a mastectomy. The ... and feel natural,” have increased sensation, and are less likely than implant reconstructions ...
(Date:6/30/2015)... ... June 30, 2015 , ... Board certified otolaryngologist Dr. Marcelo ... . , Dr. Antunes is a fellowship trained facial plastic ... In addition to performing cosmetic and reconstructive surgery on the face, he enjoys ...
(Date:6/30/2015)... ... ... James C. Wittig, MD , Vice Chairman of ... of the Skin and Sarcoma division at the John Theurer Cancer Center is ... Pathology Course. The newly installed lectures are designed to education patients, students, ...
Breaking Medicine News(10 mins):Health News:Rocky Mountain Oils Adds New CEO, Announces Relocation of Operations to Orem, Utah 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3Health News:Recent Article Advocating for Breast Reconstruction with Fat Transfers Successfully Outlines the Advantages of Transfer Procedures, Notes Beverly Hills Physicians 2Health News:Recent Article Advocating for Breast Reconstruction with Fat Transfers Successfully Outlines the Advantages of Transfer Procedures, Notes Beverly Hills Physicians 3Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 2Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 3Health News:NJ Top Doc, Dr. James C. Wittig, has Enhanced his Education Portal on TumorSurgery.org 2Health News:NJ Top Doc, Dr. James C. Wittig, has Enhanced his Education Portal on TumorSurgery.org 3
... females, males too experience sharp changes in their hormones ... brain structure of small monkeys.// ,Yevgenia Kozorovitskiy and ... of common marmosets - small monkeys that live in ... edition of New Scientist. ,The species is ...
... to put NHS general practioner and hospital consultants in its ... Limited //Company to become Alliance Boots which will be effective ... are already providing NHS Chlamydia-testing services. But a lot of ... that this is a scheming move towards NHS privatization. ...
... fellow researchers from the Mayo Clinic and Duke ... //and structure of the protein, calbindin-D28K. ... studied its interaction with the other proteins to ... the findings in the journal Nature Structural and ...
... Ph.D. and Helain Landy, M.D. of Georgetown University Medical ... family //planning while they are in medical school. ... & Gynecology journal which pointed out to the gap ... Physicians play an important role in helping a woman ...
... with at least one year’s work experience would make ... educationalist philosopher in the Journal of Medical Ethics. ... Health Policy and Practice at the University of East ... the most suitable candidates for a career in medicine. ...
... HIV-positive patient in a government hospital here, the Junior Doctors ... surgeries unless they were provided kits to protect them from ... opinion that it should be made compulsory for suspected patients ... avoid such incidents in the future," Madhya Pradesh JDA general ...
Cached Medicine News:Health News:Scientists Unravel the Mystery behind Calbindin-D28K Protein 2Health News:Gap Exists between Medical School Teaching and Physician’s Practic 2Health News:Older, More Rounded, and Artier Applicants make Better Medical Students 2
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: